TISMOO

What TISMOO does

TISMOO is a Brazilian digital health company founded in 2015 in São Paulo, originally established as Tismoo Biotech for genetic research in autism and evolved into a digital health platform dedicated exclusively to personalized medicine for Autism Spectrum Disorder (ASD), related syndromes, and other neurodevelopmental conditions. The platform combines a mobile app, a web application, the Genioo conversational AI chatbot (a GPT-type generative model specialized in autism launched in April 2024), the Saúde no Espectro ('Health on the Spectrum') coordinated care service with six operational modules, and the Tismoo.me social network integrated with medical records. Core technical components include machine learning and deep learning models for prediction and prevention, recommendation algorithms, and a structured health profile system that adapts to individual user needs, all layered on top of domain-specific data assets such as the 2,247-participant 'Portraits of Autism in Brazil in 2023' study.

The company operates a hybrid GTM motion: a direct-to-consumer freemium app for individuals, families, and caregivers, paired with a B2B2C corporate health management solution sold to enterprise HR/ESG departments and pitched to health plans and insurers. Revenue streams are described as subscription/recurring for both the health services and corporate programs, plus freemium app monetization, though pricing is not publicly disclosed. TISMOO is founder-owned, has no disclosed institutional funding or headcount figures, and maintains strategic research partnerships with Genial Care, the Muotri Lab at UC San Diego (co-founder Dr. Alysson Muotri), NASA/SpaceX for ISS brain organoid research, Mahzi Therapeutics for gene therapy clinical trials, and Instituto Mauricio de Sousa for autism-awareness content.

Name

TISMOO

Legal name

TISMOO

Website

https://tismoo.com.br

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

TISMOO is a Brazilian digital health company that provides an AI-powered platform (including the Genioo chatbot) and coordinated care services for autistic individuals, their families, and corporate ESG programs, primarily operating in Brazil.

Ownership category

akta.pro rank

Product category

Digital Health Platform for Autism and Neurodevelopmental Care

NAICS

Other Individual and Family Services (624190)

SIC

Services-Health Services (8000)

akta.pro primary industry

DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO)

akta.pro secondary industry

Telehealth/Remote ABA & Digital Behavior Coaching (EDAKAHAL)

Keywords

• Digital health platform
• Autism healthcare
• Neurodevelopment care
• Ai healthcare assistant
• Health monitoring software

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Subscription Health Services: Digital health management services offered through the Tismoo platform providing individualized monitoring, health education, and care coordination for participants with ASD, related syndromes and neurodevelopmental conditions. Delivered via app with human interaction support.
2. Corporate Health Management: Coordinated Care Model solution sold to corporate clients for employees with ASD and neurodevelopmental conditions, aimed at improving quality of life, productivity, and reducing absenteeism. Aligned with corporate ESG values.
3. App-based Freemium Services: Tismoo app offers free and premium tiers with the app downloadable from Google Play Store and Apple App Store, plus web browser access.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

TISMOO operates a digital health platform dedicated to personalized medicine and care for people with Autism Spectrum Disorder (ASD), related syndromes, and other neurodevelopmental conditions. Its core offerings include the Tismoo mobile and web app for individual health monitoring, the Genioo AI conversational assistant specialized in autism, the Saúde no Espectro (Health on the Spectrum) Coordinated Care service with six care modules, and the Tismoo.me social network integrated with medical records. The company sells both to consumers (freemium app and subscription health services) and to enterprises (Corporate Health Management program for employees with ASD and neurodivergence).

Product overview

Tismoo is a digital health platform dedicated to autism and neurodivergence, comprising the Tismoo mobile app/web platform as the core product, the Genioo AI chatbot as a key feature (GPT-type conversational AI specialized in autism), the Health on the Spectrum (Saúde no Espectro) coordinated care service with six modules, and the Tismoo.me social network integrated with medical records. The platform combines science, technology, AI, and human interaction to support autistic people and their families in health management, information access, and community connection.

Differentiator

Problem solved

Functional benefit

Brands

• Genioo: Artificial intelligence chatbot specialized in autism, neurodivergences, and neurodevelopment. A conversational robot that answers questions and explains topics related to autism, related syndromes, and neurodevelopmental conditions.

Products and services

• Tismoo Platform / App A comprehensive digital health and care platform for the entire autism spectrum, available as a mobile app (iOS and Android) and web application. Combines science, technology, and specialized content to support autistic and neurodivergent people in daily health-care routines, offering personalized guidance, health record storage, document management, and access to the Genioo AI assistant.
• Genioo AI An artificial intelligence chatbot specialized in autism, neurodivergence, and neurodevelopment. A GPT-type conversational AI that answers questions and provides information and support related to autism spectrum disorder, related syndromes, and neurodevelopmental conditions. Includes specialized assistants (teacher, doctor, psychologist, nutritionist, nurse, and more) to support daily tasks.
• Health on the Spectrum (Saúde no Espectro) — Coordinated Care Service A coordinated care service providing 360-degree health monitoring and guidance for autistic people and those with neurodevelopmental conditions. Includes six service modules: Chronic Management (GDC), Corporate Health Management, Hospitalization Management, Diagnosis Journey, Management of Complex Conditions, and Digital Health Management. Uses AI, prediction algorithms, and human interaction for evidence-based monitoring, prevention, and care navigation.
• Tismoo.me Social Network A social network integrated with a medical record system, dedicated to connecting people with autism to scientists conducting research in the field. Provides quality information and community support for autistic individuals, related syndromes, and their families.

Quantifiable outcome

• 79% of caregivers feel insecure about the future of their child with autism (from Tismoo/Genial Care research)
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability5 records

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and supporting.

• Genial CarecoreStrategic or Co-development Partner · 1 December 2023Research partnership conducting the 'Portraits of Autism in Brazil in 2023' study with 2,247 participants, providing unprecedented data on autistic people and their caregivers. The study covered topics including mental and physical health, chronic conditions, caregiver burden, and suicide data among autistic populations.
• Consultoria MayasupportingStrategic or Co-development PartnerResearch partnership on neurodiversity in the job market. Maya Consultoria conducted research on corporate neurodiversity training, finding that 86% of people have never received corporate training on neurodiversity.
• Korú Corporate UniversitysupportingStrategic or Co-development PartnerPartnership with Korú Corporate University supporting neurodiversity research and corporate training programs.
• Órbi ConectasupportingStrategic or Co-development PartnerSupporting partner in neurodiversity initiatives and corporate training research.
• NASA and SpaceXcoreStrategic or Co-development PartnerPartnership with NASA and SpaceX for Muotri Lab research involving sending autistic individuals' brain organoids to the International Space Station (ISS). This pioneering research investigates autism using space-based experiments.
• Instituto Mauricio de SousacoreStrategic or Co-development PartnerPartnership with Mauricio de Sousa Studios for the continuous development of André, the autistic character in the Turma da Mônica (Monic Gang) franchise. Tismoo supports the Instituto Mauricio de Sousa in creating autism awareness content.
• Mahzi TherapeuticscoreStrategic or Co-development PartnerTechnology partnership where Mahzi Therapeutics uses Muotri Lab technology (developed by Tismoo co-founder Dr. Alysson Muotri) for gene therapy clinical trials for autism. First autistic person received dose of gene therapy in February 2026 using this technology.
• Muotri Lab (UC San Diego)coreStrategic or Co-development PartnerResearch partnership led by Dr. Alysson Muotri, cofounder of Tismoo and professor at UC San Diego. Lab conducts advanced autism research including brain organoids, gene therapy, and space experiments with NASA/SpaceX.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Conexa Saúde: Conexa Saúde is a major Brazilian digital health/telehealth platform - comparable as a domestic Brazilian competitor in the broader digital health management space where TISMOO also operates.
• Memed: Memed is a Brazilian digital health platform providing digital prescriptions, content, and tools to physicians - a comparable Brazilian health-tech operating model with content + tech + recurring services.

Broad incumbents

• Lyra Health: Lyra Health is a large digital mental health platform sold through employers that overlaps with TISMOO's corporate wellness/ESG angle by offering mental health benefits to employees, including those with neurodevelopmental conditions.
• Cerebral: Cerebral is a US-based digital mental health platform with subscription care delivery - similar model of subscription-based digital care for behavioral/mental health conditions, though broader in scope than ASD-only.
• BetterHelp: BetterHelp operates a large direct-to-consumer telehealth/online therapy subscription platform mirroring TISMOO's freemium-to-subscription D2C model for ongoing mental health guidance.
• Spring Health: Spring Health provides employer-sponsored mental health benefits with personalized care plans - directly comparable to TISMOO's Corporate Health Management motion targeting HR/ESG buyers and neurodiversity support.

Direct peers

• Akili Interactive: Akili builds prescription digital therapeutics (including for ADHD, a related neurodevelopmental condition) - directly comparable as a regulated software-as-medical-device company targeting neurodevelopmental conditions.
• Cognoa: Cognoa builds AI-based diagnostic and digital therapeutic solutions for autism - a direct competitor developing FDA-cleared AI products for ASD identification and treatment in pediatric populations.

Emerging players

• Auticon: Auticon is a global consultancy employing autistic adults as IT consultants, addressing corporate neurodiversity hiring - directly comparable in serving enterprises seeking neurodiversity workplace solutions aligned with ESG goals.
• BehaVR: BehaVR develops digital therapeutics using AI/VR for behavioral and mental health conditions - comparable in using immersive/AI-driven software for clinical outcomes, though focused on VR rather than conversational AI.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/tismoo
• YouTubeyoutube.com/@tismoo
• Facebookfacebook.com/tismoo
• LinkedInlinkedin.com/company/tismoo
• Instagraminstagram.com/tismoo

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TISMOO